scholarly article | Q13442814 |
P2093 | author name string | C C Sanders | |
H Goossens | |||
M Ieven | |||
E Vercauteren | |||
P Descheemaeker | |||
P2860 | cites work | An IS1-like element is responsible for high-level synthesis of extended-spectrum -lactamase TEM-6 in Enterobacteriaceae | Q43675462 |
Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae | Q46855554 | ||
Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals. | Q54196261 | ||
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. | Q54316090 | ||
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | Q54380570 | ||
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. | Q54401131 | ||
Extended-spectrum beta-lactamases | Q69547842 | ||
Pulsed-field gel electrophoresis for differentiation of hospital isolates of Klebsiella pneumoniae | Q72234349 | ||
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction | Q28298254 | ||
[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction | Q29544077 | ||
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens | Q34708485 | ||
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. | Q35111741 | ||
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis | Q35114864 | ||
Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests | Q35896953 | ||
Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. | Q36530330 | ||
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. | Q36536705 | ||
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases | Q37073128 | ||
More extended-spectrum beta-lactamases | Q37520309 | ||
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322 | Q37592206 | ||
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins | Q39850194 | ||
Characterization of beta-lactamases in situ on polyacrylamide gels | Q39851784 | ||
Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae. | Q40009712 | ||
Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics. | Q41037501 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 2191-2197 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital | |
P478 | volume | 35 |
Q39455190 | Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. |
Q35598389 | Biochemical characterization of the TEM-107 extended-spectrum β-lactamase in a Klebsiella pneumoniae isolate from South Korea |
Q33682354 | Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreona |
Q54526072 | Community-acquired bacteremia with an ESBL-producing Escherichia coli strain—a case report |
Q35053795 | Comparison of disc diffusion methods for the detection of extended-spectrum Beta lactamase-producing enterobacteriaceae |
Q33964309 | Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut |
Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
Q34201311 | Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. |
Q39848627 | Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa |
Q43906446 | Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients |
Q34747622 | Extended spectrum B-lactamase mediated resistance in Escherichia coli in a tertiary care hospital |
Q35056715 | Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment |
Q24550671 | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat |
Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
Q34159849 | Extended-spectrum ß-lactamases in gram negative bacteria |
Q39555592 | Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan |
Q33966850 | Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. |
Q36055979 | Phenotypic and Molecular Characterisation of Extended-Spectrum Beta-Lactamase Producing Escherichia coli Obtained from Animal Fecal Samples in Ado Ekiti, Nigeria |
Q38966275 | Phylogenetic groups among Klebsiella pneumoniae isolates from Brazil: relationship with antimicrobial resistance and origin |
Q35646207 | Prevalence of bla (CTX M) extended spectrum beta lactamase gene in enterobacteriaceae from critical care patients |
Q44422924 | Prevalence of extended-spectrum β-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital |
Q43513283 | Prevalence of the bla (SHV) gene in Klebsiella pneumoniae isolates obtained from hospital and community infections and from the microbiota of healthy individuals in Recife, Brazil |
Q42084849 | Resistance of Klebsiella Pneumoniae clinical isolates: linkage of outer membrane proteins (omps) with production esbls. |
Q64940654 | Study of class 1 integrons in multidrug-resistant uropathogenic Escherichia coli isolated from different hospitals in Karachi. |
Q40366089 | Synthesis, spectral and extended spectrum beta-lactamase studies of transition metal tetraaza macrocyclic complexes. |
Q33976473 | Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae. |
Q33976916 | Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. |
Search more.